Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with ...

Pulse Biosciences (Nasaq:PLSE) announced today that it appointed Jon Skinner as CFO, effective Feb. 3, 2025.

Movano Health (Nasdaq:MOVE) announced today that it commenced a blood pressure clinical trial with its new cuffless wrist ...

RapidAI announced that it received FDA 510(k) clearance for its Lumina 3D automated 3D imaging reconstruction solution.

In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded ...

GE HealthCare announced a $138 million investment to expand its contrast media fill/finish manufacturing site in Cork, ...

The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.

Surmodics (Nasdaq:SRDX) today announced the successful early clinical use of its Pounce XL thrombectomy system.

ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...

Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...

Stent maker Peytant Solutions hired Dr. Craig Walker as chief medical officer and JD Simpson as chief commercial officer.

Rad AI today announced that it's raised a $60 million Series C financing round, valuing the company at $525 million.